立即開始
warrenhochfeld

Dynavax final breakout ahead of PDUFA Heplisav announcement

看多
Dynavax Technologies Corporation (NASDAQ:DVAX)  
warrenhochfeld  
NASDAQ:DVAX   Dynavax Technologies Corporation
Trend Analysis Beyond Technical Analysis
2
0
trendanalysis beyondta
Start of final bull run ahead of 9th November FDA announcement of Heplisav . $28 price projection. Final buy opportunity at $20
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。